RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ERnegative breast cancer models

By        

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1723-1732

Spandidos Publications

Access to resources Recommend Favorite

PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells

By Al-Hujaily Ensaf   Mohamed Ameera   Al-Sharif Ibtehaj   Youssef Khairia   Manogaran Pulicat   Al-Otaibi Basem   Al-Haza’a Amal   Al-Jammaz Ibrahim   Al-Hussein Khaled   Aboussekhra Abdelilah  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 97-107

Springer Publishing Company

Access to resources Recommend Favorite

Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression

By      

Molecular Medicine Reports, Vol. 6, Iss. 6, 2012-01 ,pp. : 1267-1270

Spandidos Publications

Access to resources Recommend Favorite

Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells

By        

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 2057-2065

Spandidos Publications

Access to resources Recommend Favorite

TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype

By Rahman Monzur  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 217-230

Springer Publishing Company

Access to resources Recommend Favorite